Procter & Gamble sees probability FY24 organic sales and core EPS to be at the upper end of its guidance ranges, CFO Andre Schulten stated during the company’s Q2 call. “On the EPS side, very strong performance in the front half, 17% in quarter one, 16% in quarter two sets us up well for the upper end of the guidance range, which is reflected in the tightening of the guidance. However, to keep in mind, we see a reversal of a number of effects that have supported the half one results… (For organic sales growth) So again, we reiterate the range of 4% to 5%, but we see the possibility and strong probability that we’ll be able to deliver towards the upper end of that range for the fiscal year,” Schulten stated.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PG:
- Options Volatility and Implied Earnings Moves Today, January 23, 2024
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
- Is PG a Buy, Before Earnings?
- Procter & Gamble price target lowered to $162 from $169 at JPMorgan
- Procter & Gamble price target lowered to $160 from $164 at Barclays